Skip to content
  • Facebook
  • Twitter
  • Instagram
  • Email

ORCHESTRA Cohort

A Horizon 2020 cohort

  • Project
  • Community
  • Contact

Clinical Impact of Monoclonal Antibodies in the Treatment of High-Risk Patients with SARS-CoV-2 Breakthrough Infections: The ORCHESTRA Prospective Cohort Study

A. Savoldi, M. Morra, A. Castelli, M. Mirandola, M. Berkell et al.

Contributing partner:

University of Bologna (UNIBO)

Helmholtz Zentrum München (HMGU)

University of Antwerp (UAntwerp)

Scientific article available at:

“Biomedicines“

Published August 24, 2022By aleksandr.belonozhkin
Categorized as publication

ORCHESTRA has received funding from the European Union’s Horizon 2020
research and innovation programme under grant agreement No 101016167.

Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic
EU Call: H2020-SC1-PHE-CORONAVIRUS-2020-2-RTD
Start date: 1 December 2020   End date: 30 November 2024
Coordinated by: UNIVERSITA DEGLI STUDI DI VERONA

© 2021 Orchestra. All right reserved.   Privacy Policy   Imprint